A detailed history of Meridian Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Meridian Financial, LLC holds 378 shares of LLY stock, worth $282,747. This represents 0.22% of its overall portfolio holdings.

Number of Shares
378
Previous 378 -0.0%
Holding current value
$282,747
Previous $342 Million 2.15%
% of portfolio
0.22%
Previous 0.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$724.87 - $909.04 $28,994 - $36,361
-40 Reduced 9.57%
378 $342 Million
Q4 2023

Aug 13, 2024

BUY
$525.19 - $619.13 $219,529 - $258,796
418 New
418 $244 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meridian Financial, LLC Portfolio

Follow Meridian Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Financial, LLC with notifications on news.